The high-dose flu vaccine has been proven effective in seniors, including the PACE population.

Is the High-dose Flu Vaccine More Effective for Seniors, Including the PACE Population?

Adults age 65 and older, including those in the PACE population, are susceptible to serious complications from the influenza, or flu, virus. In the United States, flu complications among seniors cost a staggering $56 billion annually, mainly driven by costs related to hospital admissions and death. This large clinical and Read more…

What phase 2 of the Final Rule will bring for post-acute care pharmacy.

Post-Acute Care Pharmacy Changes Are Coming: The Implications of CMS Final Rule Phase 2

Last year, the Centers for Medicare & Medicaid Services introduced multiple new regulations that affect long-term care pharmacy. The Final Rule for long-term care facilities participating in Medicare and Medicaid programs was published by CMS on Oct. 4, 2016.   The three phases of these regulations have implementation dates of Read more…

Long-term care pharmacy update about the link between diabetes and heart disease.

Staying Ahead in Long-term Care Pharmacy—The Link Between Heart Disease and Diabetes

post-acute care pharmacy providers. In fact, the American Diabetes Association reports that 11.2 million Americans age 65 and older—or approximately 26 percent of that population—have been diagnosed with diabetes. Many more have prediabetes, meaning they’re at risk of developing Type 2 diabetes. These numbers are important because those with diabetes Read more…

Important tips for inhaler use in the PACE population.

Inhale, Exhale: Best Practices Related to Inhaler Use in the PACE Population

Inhalers are used frequently in the elderly population, including PACE participants, to treat chronic obstructive pulmonary disease or asthma. Each inhaler works a little differently, and proper administration technique is important to ensure participants receive the appropriate amount of medication to make a difference in their disease state and improve Read more…

The future role of pharmacogenetic testing in post-acute care pharmacy.

What’s Ahead for Post-acute Care Pharmacy: Pharmacogenetics & Anticoagulation Therapy

The field of medicine is continually changing, and with it, so is long-term care pharmacy. As researchers uncover more about how the body works and metabolizes medications, the potential to personalize those medications—and optimize results—grows. The topic of pharmacogenetics is increasing in popularity as we progress toward personalized medicine. We Read more…

What long-term care providers should know about heart failure.

Heart Failure Primer and Management Strategies for Long-term Care Providers

Heart failure is a condition that’s more common among the elderly population. It is vitally important for long-term care providers, including LTC pharmacy services, to stay up-to-date on condition and management strategies. The Long-term Care Providers’ Guide to Heart Failure: Defining the Conditionm Heart failure is a syndrome that presents Read more…